Stonepine Capital Management as of Dec. 31, 2021
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 23 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amryt Pharma Plc - Spnr Sponsored Ads | 30.1 | $66M | 6.1M | 10.80 | |
| Cti Biopharma | 10.0 | $22M | 8.8M | 2.48 | |
| Xeris Pharmaceuticals (XERS) | 7.6 | $17M | 5.7M | 2.93 | |
| Adma Biologics (ADMA) | 6.4 | $14M | 9.9M | 1.41 | |
| Ovid Therapeutics (OVID) | 5.9 | $13M | 4.0M | 3.21 | |
| Evolus (EOLS) | 5.6 | $12M | 1.9M | 6.51 | |
| Conformis | 5.2 | $11M | 15M | 0.76 | |
| Exagen (XGN) | 4.6 | $10M | 859k | 11.63 | |
| Apollo Endosurgery | 4.5 | $9.7M | 1.2M | 8.43 | |
| Antares Pharma | 3.8 | $8.2M | 2.3M | 3.57 | |
| Optinose (OPTN) | 2.9 | $6.2M | 3.8M | 1.62 | |
| Diamedica Therapeutics Com New (DMAC) | 2.0 | $4.5M | 1.2M | 3.73 | |
| Atyr Pharma Com New (ATYR) | 1.8 | $3.9M | 526k | 7.47 | |
| Rezolute Com New (RZLT) | 1.8 | $3.9M | 808k | 4.78 | |
| Celcuity (CELC) | 1.4 | $3.2M | 239k | 13.19 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.3 | $2.9M | 2.3M | 1.27 | |
| Synlogic | 1.2 | $2.6M | 1.1M | 2.42 | |
| Avalo Therapeutics | 1.2 | $2.6M | 1.5M | 1.70 | |
| Biosante Pharmaceuticals (ANIP) | 1.1 | $2.4M | 52k | 46.09 | |
| Cymabay Therapeutics | 0.5 | $1.0M | 300k | 3.38 | |
| Neuroone Medical Technologies Corporation Com New (NMTC) | 0.4 | $967k | 498k | 1.94 | |
| Xoma Corp Com New (XOMA) | 0.4 | $960k | 46k | 20.86 | |
| Aldeyra Therapeutics (ALDX) | 0.4 | $800k | 200k | 4.00 |
